There will be a Molecular Basis of Leukemogenesis Seminar on Monday, October 5 at 12:00pm in the Goldman International Conference Center of the Feinstein Institute for Medical Research.
The guest speaker will be Y. Lynn Wang, MD, PhD, FCAP, professor and the founding medical director of the Genomic and Molecular Pathology at the University of Chicago Medical Center. Dr. Wang will be presenting “Laboratory Investigation of Ibrutinib Resistance in CLL”. Dr. Wang will be hosted by Drs. Kanti Rai and Nicholas Chiorazzi.
Program Objectives: Upon completion of this session, participants should be able to:
Target Audience: Researchers, Students, Hospital-based physicians, Housestaff, Nurses, and Community physicians.
CME ACCREDITATION: Northwell Health is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
CREDIT DESIGNATION STATEMENT: Northwell Health designates this live activity for a maximum of 1 AMA PRA Category 1 Credit. Each physician should only claim credit commensurate with the extent of their participation in the activity.
DISCLOSURE POLICY: Northwell Health adheres to the ACCME’s New Standards for Commercial Support. Any individuals in a position to control the content of a CME activity, including faculty, planners and managers, are required to disclose all financial relationships with commercial interests. All identified potential conflicts of interest are thoroughly vetted by Northwell Health for fair balance and scientific objectivity and to ensure appropriateness of patient care recommendations.
Planner and Speaker’s Disclosures:
Y. Lynn Wang, MD, PhD has no financial relationships to disclose.
Bettie Steinberg, PhD, faculty planner, has no financial relationships to disclose.
Recognition of Program Support: An announcement of program support will be made to all attendees at the beginning of each Regularly Scheduled Session.